Issue of Equity

Tissue Regenix Group Plc

("Tissue Regenix" or "the Company")

Issue of Equity

The Company announces that it has issued and allotted 635,674 new ordinary shares of 0.5p each in the Company following the exercise of options which were granted under the Company's EMI scheme.

These new ordinary shares will rank pari passu with the existing ordinary shares and application has been made for these new ordinary shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 08:00 a.m. on 11 July 2011. Following Admission the total number of ordinary shares of 0.5p each in issue will be 469,734,279 with each share carrying one voting right.

Contact